Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

Share Price is delayed by 15 minutes
Get Live Data
4,648.00    108.00 (2.38%)
Bid:
4,623.00
Ask:
4,625.00
Spread: 2.00 (0.043%)
Market Cap: £29.56b
RKT Live PriceLast checked at - London Stock Exchange

Intraday Reckitt Share Chart

Annual Financial Report

14 Apr 2022 12:26

RNS Number : 4442I
Reckitt Benckiser Group PLC
14 April 2022
 

14 April 2022

 

RECKITT BENCKISER GROUP PLC

("Reckitt" or the "Company")

 

2021 Annual Report and Directorate Change

 

The Company announces that it has today published its Annual Report and Accounts for the year ended 31 December 2021 (the '2021 Annual Report') on the Company's website, www.reckitt.com.

 

In accordance with Listing Rule 9.6.1, a copy of the Annual Report has been submitted to the National Storage Mechanism and will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

In conformity with DTR 6.3.5(1A) the regulated information required under DTR 6.3.5 is available in unedited full text within the 2021 Annual Report as uploaded and available on the National Storage Mechanism and on the Company's website as noted above.

 

The Company's Annual General Meeting will be held at 2pm on Friday 20 May 2022, at the London Heathrow Marriott Hotel, Bath Road, Hayes UB3 5AN. The 2021 Annual Report together with the Notice of AGM and Form of Proxy will be mailed or otherwise made available to shareholders in due course.

 

Directorate change

 

Sara Mathew has notified the Company that she does not intend to seek re-election as a Non-Executive Director at the Company's Annual General Meeting to be held on 20 May 2022. Sara has been a member of the Board and Audit Committee since July 2019.

 

Chris Sinclair, Chairman of the Board, commented "Sara has been a valuable member of the Board and Audit Committee and brought great insight to Board discussions. We would like to thank her for her significant contribution".

 

This disclosure is made in accordance with Listing Rule 9.6.11(3).

 

 

For further Information:Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

 

Richard Joyce

Head of Investor Relations

Tel +44 (0) 7408 812 062

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

  

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSFIFFLEESEEL
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20262:30 pmRNSEMTN Programme: Publication of Final Terms
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20261:26 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:32 pmRNSDirector/PDMR Shareholding
1st Jun 20262:05 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20265:42 pmRNSEMTN Programme: Publication of Final Terms
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20264:44 pmRNSResult of AGM
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:18 amRNSPublication of Supplementary Prospectus
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNS‘RECKITT FOCUS ON’ INVESTOR SEMINAR
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20262:51 pmRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20263:30 pmRNSDirector/PDMR Shareholding
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20263:00 pmRNSDirector Declaration
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSQ1 RESULTS 2026
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.